Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes

American Journal of Pathology

Volumn 156, Issue 3, 2000, Pages 751-760

  Cinti, Caterina ^a   Leoncini, Lorenzo ^b   Nyongo, Aggrey ^c   Ferrari, Filomena ^b   Lazzi, Stefano ^b   Bellan, Cristiana ^b   Vatti, Rosella ^b   Zamparelli, Alessandra ^a   Cevenini, Gabriele ^b   Tosi, Gian Marco ^b   Claudio, Pier Paolo ^d,e   Maraldi, Nadir M ^a,f   Tosi, Piero ^b   Giordano, Antonio ^d  

^a CNR   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c Nairobi Hospital   (Kenya)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN A; CYCLIN B; PROTEIN P130;

ARTICLE; BURKITT LYMPHOMA; CELL PROLIFERATION; DNA MODIFICATION; GENE DISRUPTION; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MISSENSE MUTATION; ONCOGENE C MYC; PATHOGENESIS; PRIORITY JOURNAL; RETINOBLASTOMA;

EID: 0033873789     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64941-3     Document Type: Article

References (55)

1. Sarcoma involving jaws in African children
2. Malignant lymphoma in African children. II. A pathological entity
3. The discovery of Burkitt's lymphoma
4. Childhood lymphomas resembling Burkitt's tumor in the United States
5. Childhood non Hodgkin's in the United Kingdom: Findings from the UK children's cancer study group
6. Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations
7. Chromosomal breakpoints and structural alteration of the c-myc locus differ in endemic and sporadic forms of Burkitt's lymphoma
8. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
9. Cellular kinetic and phenotypic heterogeneity in and among Burkitt's and Burkitt-like lymphomas
10. AIDS-related Burkitt's lymphoma: Morphologic and immunophenotypic study of biopsy specimens
11. What is Burkitt's lymphoma?
12. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma
13. HIV-associated malignant lymphomas in Kenya (equatorial Africa)
14. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphomas
15. Patterns of chromosomal breakpoint location on Burkitt's lymphoma: Relevance to geography and Epstein-Barr virus association
16. An alternative pathway for gene regulation by myc
17. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16(INK4A)/CDKN2,MTS2/p15(INK4B), p53, and Rb genes in primary lymphoid malignancies
18. Clinical significance of p53 mutation in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: A report of 48 cases
19. A mutant 21 cyclin-dependent kinase inhibitor from a Burkitt's lymphoma
20. Genetic alterations disrupting the nuclear localization of the retinoblastoma related gene RB2/p130 in human cell lines and primary tumors
21. The retinoblastoma gene family and its role in proliferation differentiation and development
22. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth
23. Neoplastic transformation: Oncogenes, tumor suppressors, cyclins, and CDKs
24. Cell cycle regulation of histone H1 Kinase activity associated with the adenoviral protein E1A
25. The En Vision+ system: A new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC and SABC techniques
26. Antigen retrieval techniques in immunohistochemistry: Comparison of different methods
27. Functiona analysis of pRb2/p130 interaction with cyclins
28. Retinoblastoma related p107 and pRb2/p130 proteins in malignant lymphomas: Distinct mechanisms of cell growth control
29. Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase
30. Establishment of a philogenetic survey system for AIDS-related entiviruses and demonstration of a new HIV-2 subgroup
31. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas
32. Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas
33. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein
34. The RB family of cell cycle regulatory factors
35. Degradation of E2F by the ubiquitin-proteasome pathway: Regulation by retinoblastoma family proteins and adenovirus transforming protein
36. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner
37. Role of E2F in cell cycle control and cancer
38. Differential specificity for binding of the retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein
39. E2F-4 switches from p130 to p107, and pRB in response to cell cycle reentry
40. p130 Is dispensable in perpheral T lymphocytes: Evidence for functional compensation by p107 and pRb
41. Polyomavirus large T-antigen binds the 'pRb related' protein p130 through sequences in conserved region 2
42. Regulation of the human proliferating cell nuclear antigen promoter by the adenovirus E1A-associated protein p107
43. The retinoblastoma gene famiy pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas
44. Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo
45. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes
46. Binding and suppression of the myc transcriptional activation domain by p107
47. A link between increased trasforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylationb of the c-myc transactivation domain
48. Cyclin E and c-myc promote cell proliferation on the presence of p16INK4a and hypophosphorylated retinoblastoma family proteins
49. Genetic alteration in the retinoblastoma protein-related p107 gene in human hematologic malignancies
50. The retinoblastoma protein: A regulator of cell cycle differentiation and apoptosis
51. Cellular proliferation and genetic events involved in the genesis of Burkitt Lymphoma (BL) in immune compromised patients
52. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain